Effects of recombinant factor VIIa in haemorrhagic complications of urological operations.
Department of Anaestahesiology and Intensive care Unit of the Clinical State Hospital No. 2, Szczecin, Poland.
Grazyna
G
Michalska-Krzanowska
Renata
R
Sajdak
Elzbieta
E
Stasiak-Pikuła
D000328:Adult; D015942:Factor VIIa / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous / Q000009:adverse effects; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology*; D011468:Prostatectomy / Q000009:adverse effects; D011994:Recombinant Proteins / Q000627:therapeutic use; D013520:Urologic Surgical Procedures / Q000009:adverse effects*
D011994:Recombinant Proteins; D015942:Factor VIIa